These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


385 related items for PubMed ID: 16026425

  • 1. Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.
    Smelov V, Perekalina T, Artemenko N, Smelova N, Ukleeva G, Gorelov A.
    Andrologia; 2005 Jun; 37(2-3):61-4. PubMed ID: 16026425
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
    Smelov V, Perekalina T, Gorelov A, Smelova N, Artemenko N, Norman L.
    Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
    [Abstract] [Full Text] [Related]

  • 3. Clinical and microbiological efficacy of prulifloxacin for the treatment of chronic bacterial prostatitis due to Chlamydia trachomatis infection: results from a prospective, randomized and open-label study.
    Cai T, Mazzoli S, Addonisio P, Boddi V, Geppetti P, Bartoletti R.
    Methods Find Exp Clin Pharmacol; 2010 Nov; 32(1):39-45. PubMed ID: 20383345
    [Abstract] [Full Text] [Related]

  • 4. Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination.
    Magri V, Marras E, Skerk V, Markotić A, Restelli A, Garlaschi MC, Perletti G.
    Andrologia; 2010 Dec; 42(6):366-75. PubMed ID: 21105887
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Schaeffer AJ, Wu SC, Tennenberg AM, Kahn JB.
    J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
    [Abstract] [Full Text] [Related]

  • 7. Single-drug or combined antibacterial therapy in the treatment of patients with chronic prostatitis and Chlamydia trachomatis?
    Smelov V, Gorelov A, Smelova N, Krylova T.
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S83-7. PubMed ID: 15037333
    [Abstract] [Full Text] [Related]

  • 8. Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis.
    Smelov V, Krylova T, Smelova N, Norman L.
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S79-82. PubMed ID: 15037332
    [Abstract] [Full Text] [Related]

  • 9. May Chlamydia trachomatis be an aetiological agent of chronic prostatic infection?
    Ouzounova-Raykova V, Ouzounova I, Mitov IG.
    Andrologia; 2010 Jun; 42(3):176-81. PubMed ID: 20500746
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial therapy for chronic bacterial prostatitis.
    Perletti G, Marras E, Wagenlehner FM, Magri V.
    Cochrane Database Syst Rev; 2013 Aug 12; 2013(8):CD009071. PubMed ID: 23934982
    [Abstract] [Full Text] [Related]

  • 11. [Infectious distribution and resistant of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis in the chronic prostatitis].
    Cao W, Liu L, Tong MH.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Apr 12; 28(2):177-9. PubMed ID: 12934372
    [Abstract] [Full Text] [Related]

  • 12. Role of Chlamydia trachomatis in chronic prostatitis: diagnostic investigation and therapeutic experience with miocamycin.
    Rossi R, Mora A.
    J Chemother; 1989 Jul 12; 1(4 Suppl):913-5. PubMed ID: 16312701
    [No Abstract] [Full Text] [Related]

  • 13. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Minamida S, Satoh T, Tabata K, Kimura M, Tsumura H, Kurosaka S, Matsumoto K, Fujita T, Iwamura M, Baba S.
    Urology; 2011 Dec 12; 78(6):1235-9. PubMed ID: 21908030
    [Abstract] [Full Text] [Related]

  • 14. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis.
    Skerk V, Krhen I, Lisić M, Begovac J, Roglić S, Skerk V, Sternak SL, Banaszak A, Strugar-Suica J, Vuković J.
    Int J Antimicrob Agents; 2004 Aug 12; 24(2):188-91. PubMed ID: 15288321
    [Abstract] [Full Text] [Related]

  • 15. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.
    Jeong CW, Lim DJ, Son H, Lee SE, Jeong H.
    Urol Int; 2008 Aug 12; 80(2):157-61. PubMed ID: 18362485
    [Abstract] [Full Text] [Related]

  • 16. Antichlamydial antibodies in the serum and expressed prostatic secretion in prostatitis.
    Ostaszewska-Puchalska I, Zdrodowska-Stefanow B, Badyda J, Bułhak-Kozioł V, Puciło K, Darewicz B.
    Arch Immunol Ther Exp (Warsz); 2004 Aug 12; 52(4):277-83. PubMed ID: 15467492
    [Abstract] [Full Text] [Related]

  • 17. Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
    Belliveau P, Nightingale CH, Quintiliani R, Crowe H, Gousee G.
    Conn Med; 1993 Aug 12; 57(8):539-45. PubMed ID: 8243083
    [Abstract] [Full Text] [Related]

  • 18. [In vitro activity of a new quinolone, NM 394, against Chlamydia trachomatis].
    Poutiers F, de Barbeyrac B, Garcia-Mace J, Bebear C.
    Pathol Biol (Paris); 1996 May 12; 44(5):351-4. PubMed ID: 8758474
    [Abstract] [Full Text] [Related]

  • 19. The role of Chlamydia trachomatis in prostatitis syndrome--our experience in diagnosis and treatment.
    Skerk V, Krhen I, Cajić V, Markovinović L, Puntarić A, Roglić S, Zekan S, Ljubin-Sternak S, Zidovec Lepej S, Vince A.
    Acta Dermatovenerol Croat; 2007 May 12; 15(3):135-40. PubMed ID: 17868538
    [Abstract] [Full Text] [Related]

  • 20. The role of Chlamydia trachomatis in patients with non-bacterial prostatitis.
    Mutlu N, Mutlu B, Culha M, Hamsioglu Z, Demirtas M, Gökalp A.
    Int J Clin Pract; 1998 May 12; 52(8):540-1. PubMed ID: 10622051
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.